95 results
Page 2 of 5
PRE 14A
qu6op3up6w3
4 Apr 22
Preliminary proxy
4:15pm
424B5
8ci11dviyvzup
2 Mar 22
Prospectus supplement for primary offering
8:24am
8-K
EX-99.1
sztap85 5g
11 Jan 22
Invitae Reports Preliminary 2021 Revenue of More Than $458 Million and Billable Volume of More Than 1.16 Million
4:20pm
8-K
EX-99.2
q6ooun1ztk4smzu
7 Sep 21
Invitae to Acquire Ciitizen to Strengthen its Patient-Consented Health Data Platform to Improve Personal Outcomes and Global Research
8:01am
8-K
EX-99.1
vdxalc
7 Sep 21
Invitae to Acquire Ciitizen to Strengthen its Patient-Consented Health Data Platform to Improve Personal Outcomes and Global Research
8:01am
424B5
v09evu50j t32lms11
4 May 21
Prospectus supplement for primary offering
5:10pm
8-K
EX-99.1
agcbvbhflj3 en
17 Feb 21
Invitae Reports $279.6 Million in Annual Revenue Driven by 659,000 in Billable Volume in 2020
4:09pm
424B5
2cpcog7gx9u
25 Jan 21
Prospectus supplement for primary offering
4:02pm
424B5
29tqkndlrxi5 tnwo
20 Jan 21
Prospectus supplement for primary offering
4:24pm
8-K
EX-99.2
g5p2qrtm7rt8r9eb
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
arvbd2g 75lox4mvc
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
EX-99.2
jiw827xsm zb9lom
12 Jan 21
Invitae Reports Preliminary 2020 Financial Results of More Than $278 Million in Revenue and More Than 655,000 in Billable Volume
6:06am
8-K/A
EX-99.2
3tvrojq
23 Nov 20
Consolidated Financial Statements
12:00am
424B3
jc6owd5
28 Aug 20
Prospectus supplement
4:31pm